Cystic fibrosis (CF) patients are commonly colonized by bacterial pathogens, which can 22 induce persistent lung inflammation and may contribute to clinical deterioration. Colonization 23 of CF patients and cross-transmission by Corynebacterium diphtheriae has not been reported 24 so far. The aim of this article was to investigate the possibility of a cross transmission of 25 C. diphtheriae biovar Belfanti between four patients of a CF center. C. diphtheriae biovar 26 belfanti (now formally called C. belfantii) isolates were collected from four patients in a 27 single CF care center over a 6 years period and analyzed by microbiological methods and 28 whole genome sequencing. Epidemiological links among patients were investigated. Ten 29 isolates were collected from 4 patients. Whole genome sequencing of one isolate from each 30 patient showed that a single strain was shared among them. In addition, one patient had the 31 same strain on two consecutive samplings nine months apart. The strain was non-toxigenic 32
INTRODUCTION 66
A large fraction of the mortality of cystic fibrosis (CF) patients is attributed to infections of 67 the respiratory tract, which can be caused by multiple pathogens, and cross-transmission 68 within CF centers themselves is an important healthcare related issue (1, 2) (3). The genus 69
Corynebacterium includes a high number of pathogens, most of them being opportunistic (4). 70
So far, only C. pseudodiphtheriticum, C. propinquum and C. accolens were reported from CF 71 patients (5-7). C. diphtheriae, the most pathogenic Corynebacterium species that causes 72 diphtheria, was not reported in pauci-or asymptomatic CF lung colonization to our 73 knowledge. Typical diphtheria is caused by strains that produce the diphtheria toxin. 74
Although the disease has almost disappeared in countries with high toxoid vaccine coverage, 75 the pathogen still circulates in the human population (8-10). Further, non-toxigenic 76 C. diphtheriae strains can be recovered from a variety of infections including respiratory tract 77 infections, skin infections and bacteremia (11, 12) . Three biovars of C. diphtheriae are 78 distinguished by biochemical characteristics. Whereas biovars Mitis and Gravis can harbor 79 the diphtheria toxin gene, biovar Belfanti isolates were only exceptionally described as 80 toxigenic (13) (14) (15) . Recently, C. diphtheriae biovar Belfanti isolates were recognized as 81 representing a novel species called C. belfantii (16). The aim of this study was to investigate 82 potential cross-transmission within a group of four patients with lower respiratory tract 83 colonization by nontoxigenic C. diphtheriae. These patients were followed in a single CF 84 center during a period of six years, and our genomic analyses showed that they were 85 colonized by a single C. diphtheriae strain. 86
METHODS 87

Identification of cases 88
Cases were identified in the regional consultation CF Center of a university hospital 89 between January 2011 and November 2016. During their visits at the center, patients are 90 screened for the presence of opportunistic infectious agents and the evolution of antimicrobial 91 resistance is monitored. The inclusion of cases was performed retrospectively based on at 92 least one sample positive for C. diphtheriae upon microbiological screening from sputum or 93 induced sputum. Clinical and laboratory data (sex, age at the time of diagnosis, pulmonary 94 functionality, long-term or sequential antibiotic therapies, symptomatology at the time of 95 diagnosis, respiratory co-infections) were collected for each patient. 96 97
Epidemiological investigations 98
The CF center includes three wards (consultation, pulmonary function testing and 99 chest physiotherapy) and an imaging department. The timeline of patients visits to the various 100 wards of the CF center was investigated from their clinical records. Patients undergo chest 101 physiotherapy either before or after their consultation with the physician, and a sputum 102 specimen was systematically collected. Afterwards, they are directed to the pulmonary 103 function testing ward. 104
To investigate infection control measures and detect possible factors that might have 105 favored patient-to-patient transmission, all healthcare workers of the three wards who had 106 worked during the study period were met and interviewed about implementation of standard 107 precautions, material management and patient care organization. Besides, healthcare workers 108 who were in charge of the included patients were screened based on a voluntary basis at the 109 time of the study (June to October 2017) for C. diphtheriae colonization in the nasopharynx. 110
For this purpose, swabs were plated onto blood agar medium, on which five fosfomycin disks 111 6 (50 µg/disk) were then deposited. Colonies growing around the disks after 18-24 h at 37°C 112 were sub-cultivated on Tinsdale medium agar and incubated at 37°C. (Figure 1) . The five isolates were identified as C. diphtheriae. None of the isolates was 159 toxigenic and all were of biovar Belfanti. MLST showed that the five isolates belonged to the 160 same sequence type, ST208. Whole-genome sequence variation among the 5 isolates revealed 161 only 62 SNPs among them. The largest SNP distance between two isolates was 58 SNPs, 162 observed between isolates FRC0074 and FRC0381. Hence, the five isolates were very closely 163 related, showing that they belong to a single strain. Phylogenetic analysis based on SNPs 164 (Figure S1) revealed three subtypes, comprising respectively (1) the isolate from patient 1 165 (FRC0074); (2) One isolate from patient 2 (isolate FRC0318) and the isolate from patient 3 166 (FRC0381); and (3) The other isolate (FRC0382) from patient 2 and the isolate from patient 4 167 (FRC0455). Within subtypes, only eighteen SNPs separated FRC0318 and FRC0381, and 4 168 9 SNPs separated FRC0382 and FRC0455. Following the recent description of C. belfantii (16), 169 the five isolates were re-identified based on their genomic sequence. Their average nucleotide 170 identity with C. belfantii type strain (FRC0043 T ) was 99.47%, whereas it was only 94.89% 171 with NCTC11397 T , the type strain of C. diphtheriae. Therefore, the five isolates belong to the 172 novel species C. belfantii. 173
Antimicrobial susceptibility profiles of the five isolates showed that they were 174 susceptible to all antimicrobial agents, with one remarkable exception: isolate FRC0074 from 175 patient 1 was non-susceptible to ciprofloxacin. Genomic sequence inspection showed that this In addition, patient 4 had a pulmonary function test on the same day as patient 2 in September 188 2014 and November 2016 (Figure 1) . Therefore, several opportunities for cross-transmission 189 within the CF center were identified among patients 2, 3 and 4, even though social interaction 190 between CF patients was not identified. We report four cases of CF patients colonization by non-toxigenic C. diphtheriae biovar 204
Belfanti (now formally called C. belfantii). To our knowledge, C. diphtheriae was never 205 described from CF patients. Although non-toxigenic isolates can cause a variety of infections, 206 including bacteremia (11), two patients were not symptomatic, whereas the two other had 207 lung exacerbation at the time of first C. diphtheriae detection. Other opportunist pathogens of 208 the Corynebacterium genus might be involved in CF lung exacerbations (5, 19) . In recent 209 years, C. diphtheriae became easier to identify by the use of MALDI-TOF. However, C. 210 diphtheriae may still be difficult to detect in the CF lungs, given the polymicrobial 211 colonization occurring in most samples, as was observed during this study ( Table 1) . It is 212 therefore not unlikely that additional cases of colonization might have gone undetected. 213
Multiple CF patients are typically followed in a given CF center, which creates 214 opportunities for bacterial transmission among patients despite the enforcement of strong 215 infection control measures. A strong suspicion of cross-transmission of C. diphtheriae 216 between four patients in our clinic arose given the repeated observation of patients colonized 217 by C. diphtheriae. Microbiological investigations fully supported the hypothesis of a single 218 strain. MLST showed that the five isolates belonged to the same sequence type. The MLST 219 genotype of the isolates, ST208, was not reported previously in the C. diphtheriae MLST 220 database, suggesting that it is not common. Whole genome sequencing defines the genetic 221 relatedness among C. diphtheriae isolates with high precision (20) (21) (22) . This approach 222 demonstrated that the five isolates belong to the same strain and provided strong support to 223 the hypothesis of cross transmission among patients and/or contamination from a common 224 source. Besides, the data showed that the strain persisted within patient 2 for at least 9 225 months. Unfortunately, the additional isolates detected from patient 2 and 3 were not stored. 226
12
The SNP variation uncovered by the genomic analysis reflects evolution of the strain 227 since the last common ancestor of the five isolates. Three subtypes were distinguished, two of 228 which comprised isolates from two patients. Subtypes shared by patients may reflect direct 229 transmission between them. Epidemiological investigations support this possibility in one 230 case, as patients 2 and 3 had simultaneous visits to the CF center on several occasions. 231
However, knowledge on subtype diversity within patients would be required to infer 232 transmission chains with confidence (23) . In this study, only one isolate was kept and 233 characterized from each sample. Therefore, one cannot exclude that subtypes coexisted within 234 single patients, which would lead to the possibility of other transmission patterns than those 235 suggested by the phylogeny. 236
Biovar Belfanti of C. diphtheriae (C. belfantii) is commonly isolated from the respiratory 237 tract, generally from the nose or throat and often in association with ozaena (24). In contrast, 238 its isolation from skin infections is extremely rare. Therefore, skin wounds of patients or the 239 personnel is an unlikely reservoir. Transmission by direct respiratory contamination between 240 patients appears as the most likely transmission route. Transmission of C. striatum in an 241 intensive care unit and silent transmission of C. pseudodiphtheriticum among CF patients 242 were previously reported (5, 25). 243
Evolution of antimicrobial resistance occurs frequently in bacterial isolates that colonize 244 CF lungs (26). Our results showed ciprofloxacin resistance in one isolate, whereas the others 245 were susceptible. As no prescription of quinolone antimicrobials was recorded for this patient, 246 one possibility is that the strain had evolved resistance to ciprofloxacin in another 247 ciprofloxacin-treated patient, in which the strain was not detected. 248
The main limitation of this study is that the infection control investigation was performed 249 retrospectively and that no detailed pattern of transmission could therefore be ascertained. 250
Healthcare workers or the materials used for patient care may have played the role of vector 251 13 of C. diphtheriae between the patients (27), even though the retrospective screening did not 252 reveal a potential carrier or source of infection. Further, hidden patient-to-patient cross 253 transmission cannot be excluded, as some patients may have been undetected for 254 C. diphtheriae carriage. Further studies are needed to better define carriage of C. diphtheriae 255 by CF patients and to investigate the possible role of patients, healthcare workers or 256 environmental sources in cross transmission. In addition, the clinical significance of non-257 toxigenic C. diphtheriae will need to be determined in order to define strategies of treatment, 258 prevention and control of contamination of CF patients by this bacterial pathogen. 259 260 Acknowledgements 261
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